Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It’s “hump day” and the filing deadline is Friday (by 11:59 p.m.).
With regards to 2nd Amended Complaint.
Imo.
It seems like we are at an important inflection point for what the business model will become. Either a larger pharma swoops/swooped in, or multiple combo commitments with multiple BP.
If the RFI looks standard, or is not needed, and if, as I suspect, the QALY has already been calculated and informally price an internal known for pre and post closed system automation, then really, we are at a point where LP starts signing the planned combos or we’re bought out before those commitments can be finalized. IMO.
Keep asking myself. It seems like a larger BP would want to swoop in before tens of contracts with other larger BPs likely occur, doesn’t it? Or, are all of them content to divvy up the platform potential combinations?
Retrenching.
You are in my thoughts and prayers. God Bless. You’ve got this.💪
Losing Toxic Chemo
And 3.5 days until deadline to file Second Amended Complaint.
Timely.
You are being very sincere. I like GC’s persona, but I don’t read him anymore because he uses jtm censors when he knows the censor count was changed over time at SNO a year and a half or so later. He knows this, but he persists. So why read him. I’ll read him again when he uses real comparisons over time. He can use the jtm, but he then also needs to use the SNO censoring data after that a year or so after that (and the JAMA, which he does use).
I wasn’t disagreeing, just providing timeframe context.
I assume there are many parties, inside and outside the case, potentially discussing next steps this week.
If the 80 day clock were to have started when Senti thought, 80 days would be yesterday or today.
If the 80 day clock started as responses from MHRA (aka: starts after validation confirmation) seemed to indicate along with
Schedules for management seemed to indicate from emails (aka Jan 4 or earlier) to derivative court, the 80 days would end sometime between March 21 and about about March 26.
That said. 80 days is not required. It’s just supposed to be within 80 days. Target.
I believe Posner/Sarola can file as late as Friday at 11:59 p.m. est.
I think scientometric analysis is pseudoscience.
This week.
Honestly, doc, you are better than shorts at getting long time investors in a funk.
And don’t forget the additional DCVax-l case report on an individual with a 50% inoperable tumor regressing accepted by a journal. Something is definitely up, imho.
Henry and Captain, something is up. Two mainly DCDirect patents granted in Israel within the past month. Essentially for inoperable/advanced. One could see this indication treated as emergency type approval by certain regulators.
And,
$NWBO Patent application with completed examination - 🇮🇱 IL256522 - Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response
— Henry (@HenryMuney) March 9, 2024
Next steps: Payment for acceptance fee and issuance. pic.twitter.com/zNyPev4t5F
I just said Gilead was an ethical company.
If you read the board, you’d see hyperopia just gave an example of a small company being frustratingly purchased on the cheap.
If one of the BP and their tentacles think they can devalue NWBO, I’d hope an ethical company comes in and swoops their conquest out from under them with a fair starting bid.
Don’t tell Doc Logic though, he doesn’t want any bids in the foreseeable future.
Of course there are ethical transactions that can break the mold. Gilead was an ethical player. For instance, it dared to cure hepatitis C.
That doesn’t change the fact that there are small biotech companies whose market caps are beaten down by unscrupulous players, and then those small biotech companies are bought for cheap.
Your argument that some unscrupulous players would rather buy a company for more because that high purchase cost would eventually enable them to sell their product for more goes in the category of silly.
Not something you have to prove when alleging spoofing.
However, Merck is one of Citadel’s investment arm’s largest holdings.
This may come as a surprise, but BP do better financially if they buy brilliant small companies on the cheap after the small brilliant companies have their market cap beaten to a fricking pulp.
This may also come as a surprise, but Citadel profits from companies that also own BP. Many of those companies want small brilliant company market caps beaten to a fricking pulp.
This may also come as a surprise, but large hedge fund/brokerages/market makers have high incentive to break firewalls and little worry about regulators enforcing disabled firewalls. Wet noodle wrist slaps.
I’ve never seen a shareholder not want an initial offer more than DocLogic. It defies logic. Bare minimum, we stop diluting at half a dollar.
RFI is very common, although, then again, I don’t know of any other company that’s hired two maa editors, and spent months conducting mock inspection preparations.
In December, on announcing maa submission, the company themselves expected an RFI as part of the typical process.
Effectively, imo, the motion to dismiss has already been denied. While legally granted, the right to specifically cure by amendment regarding causation, combined with Ms. Posner’s guarantee they are “fully prepared” to provide exactly what the court asks for and anything else, means that the time for settlement possibility that you are talking about starts now, imo. Particularly with the cookie cutter amended pleading eagerly awaited by all kinds of companies within the week.
Not on mine. For years, the app has given me real time, now it exclusively delayed NWBO from real time, all others on watchlist app remain real time.
For the last half hour now, NWBO trade postings have been delayed 15 minutes on CNBC. All other companies are within seconds of real time.
It is a bizarre world when money traders believe they are more entitled than the companies they provide liquidity for. It’s as if the “market makers” of this world see their penny skimming billion dollar schemes as more important than cancer research, sattelite innovation, electric transportation developments and artificial intelligence.
They are figuratively and literally too big for their britches.
Thanks for adding the transcript link.
I know I’m probably wrong, but my guess is that there’s a strong possibility of near term settlement in the MM case.
My reasoning is based upon easily publicly available material — court rulings, newspaper articles, etc.
I’m not going to go into my reasoning, as it’s quite possibly wrong anyway. I’ll just say the magistrate's recommendation is not being clearly spelled out by some in the media, and I don’t think this is by chance.
Still, I would not be surprised to see the case go forward, and my assumptions be found lacking.
We are essentially a week from the 2nd amended complaint filing deadline.
According to his responses here, Nemesis19 was never admitted into the clinical trial. In fact, he states he was only ever offered standard of care. At first, he tried to make it seem he was duped into a trial. It later appears he was only offered standard of care and never offered any trial therapy.
I don’t believe Nemesis19 was a patient, but is a message poster parading around patient records, with or without patient permission.
His language errors are that of a non-native english speaking foreign national, or of someone trying to feign being a non-native English speaking foreign national.
Just my opinion.
Who was the “oncologist” you were referred to after being called by the nurse specialist and being told you have two weeks to live?
Who was your surgeon?
Was your tumor tissue wax paraffined or frozen?
I know, so what’s he going on about? If he wasn’t randomized, the screening process did its job.